Equinor ASA Launches NOK 1.97 Billion Share Buy-Back Program
Equinor ASA initiates a NOK 1.97 billion share buy-back program to support employee share programs, enhancing workforce engagement in the petroleum refining sector.
Radiopharm Theranostics reports director interest changes
Radiopharm Theranostics Ltd discloses changes in director interests, emphasizing transparency and compliance in the pharmaceutical preparations sector.
Equinor ASA announces third tranche of share buy-back for 2026
Equinor ASA reveals third tranche of share buy-back for 2026, purchasing over 540,000 shares at NOK 425.48 each to enhance shareholder value.
Rentokil Initial CFO Paul Edgecliffe-Johnson to Retire
Rentokil Initial plc announces CFO Paul Edgecliffe-Johnson's retirement effective January 31, 2027, initiating a search for his successor.
KB Financial Group reports decrease in major shareholder's stake
KB Financial Group Inc. notes a small decrease in shares held by its largest shareholder, the Korean National Pension Service, in recent SEC filing.
Sasol Ltd Reports Operational Updates in Recent Filing
Sasol Ltd's latest filing reveals important operational updates that may influence the crude petroleum and natural gas sector.
BrenX Ltd. Plans Special Meeting for Proposed Reverse Split
BrenX Ltd. announces a Special General Meeting on November 6, 2026, to vote on a reverse share split proposal, impacting shareholders and the heating equipment industry.
Solowin Holdings approves share consolidation and capital increase
Solowin Holdings, Ltd. announces approval for share consolidation and capital increase, aiming to enhance financial stability and market presence.
Euroseas Ltd. Announces New Charter and Vessel Sale
Euroseas Ltd. secures a new charter for M/V EM Corfu and sells M/V Evridiki G, enhancing revenue and operational efficiency in the shipping industry.
BMO Announces Executive Appointments for U.S. Operations
Bank of Montreal appoints Tim Cox as U.S. Country Head and Darrel Hackett as Executive Vice-Chair, marking significant leadership changes.
Emera Inc. announces arrangement agreement with ATCO Ltd.
Emera Inc. has filed a 6-K detailing its arrangement agreement with ATCO Ltd. and Canadian Utilities Limited, signaling a strategic shift in the electric services sector.
STRATS SM Trust Announces Distribution to Certificate Holders
STRATS SM Trust for Goldman Sachs Cap I SEC Series 2005-3 announces a distribution of $89,316.59 to certificate holders, reflecting ongoing activity in asset-backed securities.
STRATS Trust for Goldman Sachs Capital I Announces Distribution
STRATS Trust for Goldman Sachs Capital I Securities announces a distribution to certificate holders, reflecting ongoing activity in the asset-backed securities sector.
Green Brick Partners Appoints Jed Dolson to Board of Directors
Green Brick Partners, Inc. appoints Jed Dolson to its Board of Directors, expanding governance and signaling strategic growth in the operative builders sector.
Federal Home Loan Bank of Chicago Elects New Directors
Federal Home Loan Bank of Chicago announces new board members, enhancing leadership and representation in the federally-sponsored credit agency sector.
Delek Logistics Partners Declares Quarterly Distribution of $1.14
Delek Logistics Partners, LP announces a quarterly cash distribution of $1.14 per unit for Q3 2026, reflecting its commitment to unitholders.
Starz Entertainment signs new contract with CFO Scott Macdonald
Starz Entertainment Corp. has extended CFO Scott Macdonald's contract through 2028, emphasizing stability in leadership in a competitive industry.
TriLinc Global Impact Fund reports $283 million portfolio update
TriLinc Global Impact Fund LLC shares a portfolio update revealing $283 million in assets and significant repayments, impacting the finance services sector.
XBiotech appoints Co-CEOs in leadership transition
XBiotech Inc. announces Dr. Sushma Shivaswamy and Jan-Paul Simard as Co-CEOs, marking a pivotal leadership change in the pharmaceutical industry.
Perspective Therapeutics announces clinical trial results update
Perspective Therapeutics shares updated interim results from its clinical trial for a new treatment targeting neuroendocrine tumors, presented at a major congress.